Embolic Protection Devices Market size is projected to surpass USD 2.5 billion by 2030, according to a new research report by Global Market Insights Inc.
The report identifies technological advancements in embolic protection devices and the rising prevalence of the patient population aiding the adoption of novel products as the chief drivers for the industry. Key players are focusing on developing advanced devices, which are also affordable.
According to the EUROSTAT report 2022, more than one-fifth (20.8%) of the total EU population was aged 65 and over. Therefore, with the rising geriatric population, who are more prone to health conditions, along with growing instances of chronic diseases and cardiovascular ailments, the demand for peripheral vascular procedures and percutaneous coronary interventions is likely to increase, boosting product demand.
High adoption for surgical & non-surgical interventions to increase proximal occlusion systems industry share
Embolic protection devices market from proximal occlusion systems segment is estimated to reach USD 443 million by 2030. The segment will grow massively as proximal occlusion systems prevent plaque interruption during the placement of embolic protection devices. This enables the crossing of stenosis under protection, which will boost its adoption in various surgical and non-surgical interventions, thereby fueling the demand for proximal occlusion systems in the coming years.
Browse key industry insights spread across 160 pages with 221 market data tables & 17 figures & charts from the report, “Embolic Protection Devices Market Analysis By Product (Proximal Occlusion Systems, Distal Occlusion Systems, Distal Filters), By Application (Cardiovascular Disease, Peripheral Disease, Neurovascular Disease), By Material (Polyurethane, Nitinol), By End-use (Ambulatory Surgical Centers, Hospitals), Industry Analysis Report, Regional Outlook Growth Potential, Industry Analysis Report, Competitive Market Share & Forecast, 2022 – 2030” in detail along with the table of contents:
Easy operational quality to push the demand for nitinol-based embolic protection devices
The embolic protection devices market from the nitinol segment was over 63% in 2021 and is slated to amass substantial gains by 2030. A thin-layered nitinol-created embolic protection device can shrink and enter suggestively compact-diameter catheters. Moreover, easy deployment of nitinol embolic protection devices through highly narrow or convoluted vascular systems will propel their utilization in a wide range of catheter-based procedures, thereby accelerating segment growth.
Others end-use segment to benefit from easy availability of the clinics and centers
As per the report, the embolic protection devices market is divided based on end-use into ambulatory surgical centers, hospitals, and others. The others segment, which includes cardiac centers, clinics, etc., accounts for significant uptake of embolic protection devices as a large population has easy access to cardiology processes in clinics, cardiac centers, nursing homes, and more. The others segment reached more than USD 280 million in 2021.
Growing number of patients with peripheral arterial disease to augment market outlook
Peripheral disease application segment is estimated to register 8% CAGR between 2022 and 2030. This is driven by surging cases of patients suffering from peripheral arterial disease (PAD), which makes them extremely susceptible to acute limb ischemia (ALI). ALI occurs due to thromboembolism in atherosclerotic plaques, which is augmenting the demand for embolic protection devices in these treatment procedures.
Europe emerges as a prominent revenue pocket for embolic protection devices industry expansion
Europe embolic protection devices market is set to cross USD 875 million by 2030. The region may emerge as a major hub for this industry owing to increasing instances of cardiovascular diseases, strong presence of R&D centers, and swift adoption of novel technologies to enhance the healthcare system. Prominent focus on decreasing the risks of chronic illnesses among the geriatric population is also poised to push the regional market revenue.
Technological advancements to remain a key growth strategy
Some of the key players profiled in the embolic protection devices industry report include Allium Medica, Abbott Laboratories, Boston Scientific Corporation, Cardinal Health, Edwards Lifesciences Corporation, W. L. Gore & Associates (Gore Medical), Contego Medical, LLC, Innovative Cardiovascular Solutions, LLC, Keystone Heart, Medtronic, Metactive Medical, and Transverse Medical, Inc.